What does material adverse effect mean?
An MAE, sometimes written as material adverse change or MAC, is a defined term describing a deterioration in the target’s business severe enough to excuse the buyer from its obligation to close the deal.
The definition does three jobs inside a purchase agreement. It qualifies the seller’s representations, so that minor inaccuracies do not add up to a breach. It appears in the closing conditions, where the buyer’s obligation to fund is conditioned on no MAE having occurred since signing. And it runs through the interim operating covenants that govern the business between signing and closing. The same defined term carries different weight in each location, which is why the drafting fight is worth having in all three.
Most agreements define an MAE circularly, as any event, change, or effect that has had or would reasonably be expected to have a material adverse effect on the business, financial condition, or results of operations of the company. The real content of the definition lives in the carve-outs.
What are the standard MAE carve-outs?
Carve-outs are the categories of bad news that do not count toward an MAE, no matter how damaging. The standard list includes general economic and financial market conditions, conditions affecting the target’s industry as a whole, war and terrorism, natural disasters and pandemics, changes in law or accounting standards, the announcement or pendency of the transaction itself, and the seller’s compliance with the agreement.
Sellers negotiate the carve-outs broad, because they convert systemic risk into the buyer’s problem the moment the ink dries. Buyers respond with a disproportionate-impact exception: a carved-out event counts after all if it hits the target materially harder than its industry peers. Where that line sits, and whether the exception swallows the carve-outs, is a genuine negotiation with real economics attached, the same way reps and warranties and their survival periods carry economics.
Has a court ever actually found an MAE?
Almost never, and the case law is instructive about where the bar sits.
In 2001, Tyson Foods tried to walk away from its merger with IBP after IBP’s earnings fell and an accounting issue surfaced. The Delaware Court of Chancery ordered the deal to close, holding that an MAE requires deterioration that is consequential to earnings power over a commercially reasonable period, measured in years rather than months. A bad quarter, or even a bad year in a cyclical business, does not qualify.
The first Delaware decision to uphold a buyer’s MAE termination came in 2018, in Akorn v. Fresenius. Akorn’s EBITDA had collapsed roughly 86 percent after signing, and diligence surfaced systemic data-integrity failures in its FDA submissions. The court found both a general MAE and a breach of the regulatory representations, and let Fresenius walk. During the pandemic, Delaware refined the doctrine again in AB Stable, holding that COVID-19 fell within a natural-disaster carve-out but that the seller’s drastic operational changes breached the ordinary-course covenant, which excused the buyer anyway. The interim covenants can matter more than the MAE definition itself.
How is an MAE actually used in practice?
Formal MAE terminations are rare because the litigation bar is high and the remedy uncertain. The clause’s real function is leverage. A buyer facing deteriorating target performance between signing and closing does not usually sue; it calls and proposes a price reduction, with the MAE argument as background pressure. Sellers with weak definitions, thin carve-outs, or long gaps between signing and closing are the ones who take those calls.
Three drafting choices compress that risk. Broad carve-outs with a narrow disproportionate-impact exception keep systemic shocks off the table. Forward-looking language, what would reasonably be expected to result in an MAE, gets resisted, since it invites speculation. And the signing-to-closing window gets shortened, because every additional month is another month of MAE exposure. Deal speed is a risk-allocation tool, which is one reason a prepared, competitive sell-side process protects price after signing, not just before it.
Questions founders ask
What is a material adverse effect in an M&A agreement?
An MAE is a negotiated contract standard that defines how severe and durable a deterioration in the target business must be before the buyer can refuse to close or terminate the agreement. It appears as a qualifier on representations, as a closing condition, and inside the interim covenants.
Has a court ever found a material adverse effect?
Rarely. Delaware turned back MAE claims for decades, including Tyson’s attempt to exit its merger with IBP in 2001. The first Delaware decision upholding a buyer’s MAE termination was Akorn v. Fresenius in 2018, where EBITDA had fallen roughly 86 percent and serious regulatory failures had surfaced.
What are MAE carve-outs?
Carve-outs exclude categories of risk from the MAE definition, typically general economic conditions, industry downturns, war, pandemics, changes in law, and the announcement of the deal itself. Sellers negotiate them broad, usually subject to a disproportionate-impact exception.
Why does the MAE clause matter to a founder selling a company?
It allocates the risk of bad news between signing and closing. In practice buyers use MAE arguments to reprice rather than to walk, and the defense is a tight definition, broad carve-outs, and a short signing-to-closing window.
Published August 25, 2026 by Jeff Barrington, Founder and Managing Director, Windsor Drake. Content on this page may be cited with attribution and a link to https://windsordrake.com/material-adverse-effect/